A YEAR IN REVIEW

Our Key Figures

icon-total-staff
2609
TOTAL STAFF
icon-research-staff
1331
RESEARCH STAFF
women-staff
63.66
%
WOMEN STAFF
icon-number-publications
1501
NUMBER OF
PUBLICATIONS
icon-total-impact-factor
7.13
AVERAGE IMPACT FACTOR
icon-publications-leadership
43.6
%
PUBLICATIONS LEADERSHIP
icon-new-project-01
208
NEW PROJECT
& HR GRANTS
icon-grants-funding-01
29.05
M€
GRANTS FUNDING
icon-active-clinical-01
515
ONGOING PROJECTS
icon-intramural-number-01
25
NUMBER OF INTRAMURAL PROJECTS & HR GRANTS
icon-intramural-suport-01
1.85
M€
INTRAMURAL INVESTMENT TO SUPPORT TO RESEARCH
icon-intramural-hr-01
1.14
M€
INTRAMURAL INVESTMENT ON HR GRANTS
icon-new-clinical-01
244
NEW CLINICAL STUDIES
icon-active-clinical-02-01
1039
ACTIVE CLINICAL STUDIES
icon-new-pacient-03-01
638
NEW PATIENT INCLUSION
icon-licensed-patents-01
2
LICENSED PATENTS
icon-spin-off-01
1
SPIN-OFFS/START-UPS APPROVED
icon-revenue-innovation-01
1.37
M€
REVENUE FROM INNOVATION

Top Stories

Top Scientific advances
foto-reacreditacio-isciii
Renewal of the accreditation as a health research institute by the ISCIII

Renewal of the accreditation as a health research institute by the ISCIII

foto-IA
AI is gaining prominence in biomedical research

AI is gaining prominence in biomedical research

Highlights

eCORE

Global Health

The aim of this eCORE is the study of those diseases that have a global impact in society. The groups will promote research diseases that affect a large number of people in order to improve society’s well-being and public health.

RESEARCH GROUPS

malalties-infeccioses
486
Publications
8.58
Average Impact Factor
75.51
%
%Q1

Chronic, Prevalent Diseases & Aging

This eCORE focuses on the study of chronic and prevalent diseases along people’s life, and the effect of aging in society’s well-being.

RESEARCH GROUPS

biologia-vascular-metabolisme
869
Publications
7.78
Average Impact Factor
73.53
%
%Q1

Woman & Child Health & Rare Diseases

The main objectives of this eCORE are the study of diseases that affect women and children, including maternal diseases and paediatric and early ages health issues, as well as rare diseases affecting a small number of people.

RESEARCH GROUPS

malalties-minoritaries
628
Publications
6.32
Average Impact Factor
69.75
%
%Q1

Brain & Mind and Behaviour

Research groups affiliated to this eCORE are focused on the study of diseases affecting the brain, mind and/or behaviour. These clinical conditions have a high personal, social and economic burden, leading to disability and reducing quality and life.

RESEARCH GROUPS

326
Publications
7.76
Average Impact Factor
75.46
%
%Q1

Cancer

The aim of the Cancer eCORE is to improve the outcome and quality of life of cancer patients. Cancer eCORE directs its efforts to unveil and understand the mechanisms of the cancer origin and progression. The ultimate goal is to translate this knowledge into new diagnostic, prognostic and therapeutic solutions. Our bench to bed comprehensive research includes the generation of relevant disease models, biomarker studies, drug development and clinical trials.

RESEARCH GROUPS

oncologia_0
286
Publications
5.87
Average Impact Factor
72.03
%
%Q1

Personalised Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health

Being the largest, the objective of this eCORE is the development of new diagnostic tools and the promotion of personalized medicine based or not on digital health through the use of molecular imaging and other medical imaging technologies, biochemistry, pharmacy, pathology anatomy, omics data and related disciplines.

RESEARCH GROUPS

immunologia
654
Publications
7.05
Average Impact Factor
73.24
%
%Q1

Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation

This eCORE is focused on the development of novel cutting-edge treatment and interventions, based on advanced therapies, nanomedicine and innovative surgical and transplant/donation procedures, with the clear aim of making such progresses readily available to patients in need.

RESEARCH GROUPS

660
Publications
7.09
Average Impact Factor
71.82
%
%Q1

Best Scientific Images

Partners and Acknowledgements

In this section we want to thank the support of the board of trustees and other governing bodies, the entities that have placed their trust in us by financing research projects, as well as all the citizens and patient’s associations because through their private donations they contribute to providing research funds. And, finally, to the patients and their families for their generosity in helping us on a day-to-day basis, whether in defining our mission, placing themselves at the center of research since they are the first to benefit, either as volunteers in the clinical trials.